Efficacy of Different Acupuncture Methods for Chronic Low Back Pain

Not Applicable

Completed

• Conditions: Chronic Low Back Pain
• Interventions: Other: Acupuncture 1; Other: Acupuncture 2

• Registration Number: NCT00758017
• Lead Sponsor: Charite University, Berlin, Germany

Brief Summary

The aim of the study is to evaluate pain intensity over 8 weeks in acupuncture patients with chronic low back pain and to compare 2 different groups of patients which differ in the acupuncture method used to treat the pain.

Detailed Description

Not available

Study Timeline

• Study First Submitted: 2008-09-22
• Study First Submitted QC: 2008-09-22
• Study First Posted: 2008-09-23
• Study Start: 2009-01
• Primary Completion: 2011-03
• Status Verified: 2011-06
• Study Completion: 2011-06
• Last Update Submitted: 2011-06-21
• Last Update Posted: 2011-06-22

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 150

Inclusion Criteria

• diagnosis of chronic low back pain (for at least 3 months) confirmed by a consultant
• indication for treatment of low back pain with acupuncture confirmed by a consultant
• at least 40 mm on a VAS pain scale

Exclusion Criteria

• acupuncture during the last 6 months
• start of a new therapy for low back pain within the last 4 weeks
• pregnancy
• substance or drug abuse

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Arm && Interventions

Group	Intervention	Description
Acupuncture 1	Acupuncture 1	-
Acupuncture 2	Acupuncture 2	-

Primary Outcome Measures

Name	Time	Method
Pain intensity over 8 weeks (area under the curve)	8 weeks

Secondary Outcome Measures

Name	Time	Method
Sick leave days	baseline, at week 8, at week 26
Number of therapy sessions	baseline to expected time frame 3 months
Intensity of back pain at week 8 and week 26	baseline, week 8, week 26
Back function (FFbH-R)	baseline, week 8, week 26
QoL	baseline, week 8, week 26
Days with medication intake	baseline to end of week 8
Days with physical therapy because of back pain	baseline to end of week 8
Duration of therapy	baseline to expected time frame 3 months
Adverse effects and severe adverse effects	baseline to expected time frame 3 months

Trial Locations

Locations (1)

ambulatory practice Yang-Strobel; 🇩🇪 Berlin, Germany